| Closing Price ($) | Shares Out (MM) | Market Cap ($MM) |
| $0.00 | 0 | $0 |
| 10-Q | 2018-09-30 | Quarter: 2018-09-30 |
| 10-Q | 2018-06-30 | Quarter: 2018-06-30 |
| 8-K | 2019-03-29 | Accountant, Exhibits |
| Comps ($'000 TTM) | Market Cap | Assets | Liabilities | Revenue | Gross Profit | Net Income | EBITDA | EV |
|---|---|---|---|---|---|---|---|---|
| Apollo Education (APOL) | 1,063,295 | 1,955,243 | 886,324 | 2,000,328 | 0 | -19,719 | 98,213 | 579,272 |
| China Crawfish (CACA) | 2 | 0 | 0 | 0 | -4 | -4 | -3 | |
| Mirenco (MREO) | ||||||||
| Weyland Tech (WEYL) | 10,602 | 5,280 | 29,462 | -958 | -4,242 | -4,099 | -5,303 | |
| Lingo Media (LMDC) | 1,302 | 743 | 0 | 0 | 0 | 0 | -0 | |
| Granite Real Estate (GRP) | ||||||||
| Wewin Group (WWIN) | 26 | 114 | 5 | 20 | -95 | -95 | -20 | |
| MWF Global (MWF) | 0 | 0 | -34 | -34 | -1 | |||
| Frontier Digital Media Group (FDMG) | 5 | 31 | 32 | 0 | -29 | -29 | -3 | |
| Brighthouse Life Insurance Co of Ny (BHNY) | 9,065,749 | 8,029,864 | 236,819 | 0 | 0 | 2,514 | -190,199 | |
| G-Mes Holdings (GMES) | 1,262 | 812 | 652 | 609 | 67 | 141 | -31 | |
| Baynon (BNON) | 11 | 145 | 0 | 0 | -21 | -20 | 99 | |
| Immune Therapeutics (IMUN) | 0 | 24 | 12,553 | 0 | 34 | -5,080 | -5,079 | -21 |
| Green Planet Bio Engineering (GPLB) | 3,001 | 0 | 272 | 0 | 0 | -38 | -38 | 3,001 |
| Blue Sphere (BLSP) | 894 | 43,956 | 86,868 | 7,950 | 2,700 | -14,453 | -14,295 | 8,802 |
| Therapeutic Solutions (TSOI) | 0 | 367 | 1,851 | 13 | 10 | -1,579 | -1,236 | 481 |
| Stem Holdings (STEMH) | 40,803 | 5,703 | 958 | 364 | -8,070 | -7,496 | -5,454 | |
| SpringWorks (SWTX) | ||||||||
| Clean Coal Technologies (CCTC) | 27 | 16,749 | 0 | 0 | -5,795 | -3,052 | 894 | |
| Ryanair Holdings (RYAA) | 13,250,700 | 8,035,800 | 0 | 0 | 0 | 0 | -34,900 |
| Balance Sheet ($'000) | 2018-06-30 | 2018-09-30 |
| Cash | 82 | 145 |
| Accounts Receivable | 421 | 479 |
| Inventory | 9 | 18 |
| PP&E | 753 | 757 |
| Assets | 1,149 | 1,262 |
| Accounts Payable | 226 | |
| Long-Term Debt | ||
| Liabilities | 1,164 | 812 |
| Stockholders' Equity | -16 | 450 |
| Income Statement ($'000) | 2018-06-30 | 2018-09-30 |
| Revenue | 341 | 311 |
| Cost of Revenue | 48 | -6 |
| Gross Profit | 293 | 316 |
| R&D | ||
| SG&A | ||
| Tax | 0 | 0 |
| Net Income | 39 | 28 |
| Cash Flow ($'000) | 2018-06-30 | 2018-09-30 |
| Cash Operating | -87 | |
| Cash Investing | -6 | |
| Cash Financing | 154 |